Showing results (1181-1190 of 1,260) with videos related to
Sort By:
Pageof 126
Anesthesia and Analgesia|May 22, 2026
Associations Between Time to Reduction and Complications in Patients With First-Time Total Hip Arthroplasty Dislocation: A Retrospective Cohort StudyRikke H F Bjulf, Rasmus L Knudsen, Aurelien-Xuan R Bahuet, et al.Journal of Internal Medicine|June 22, 2010
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general populationJ Eugen-Olsen, O Andersen, A Linneberg, et al.JAMA|January 10, 2008
Variation of breast cancer risk among BRCA1/2 carriersColin B Begg, Robert W Haile, Ake Borg, et al.Frontiers in Microbiology|January 24, 2022
Insight Into the Anti-staphylococcal Activity of JBC 1847 at Sub-Inhibitory ConcentrationTroels Ronco, Line H Kappel, Maria F Aragao, et al.Journal of Hypertension|March 14, 2007
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studiesWouter B A Eijkelkamp, Zhongxin Zhang, Barry M Brenner, et al.International Journal of Cancer|November 11, 2006
Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registriesLorenzo Richiardi, Ghislaine Scélo, Paolo Boffetta, et al.Journal of Hypertension|August 18, 2004
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudyHans Ibsen, Kristian Wachtell, Michael H Olsen, et al.Hepatology Communications|September 1, 2023
Suboptimal diagnostic accuracy of ultrasound and CT for compensated cirrhosis: Evidence from prospective cohort studiesLiv E Hetland, Thit M Kronborg, Mira Thing, et al.Hypertension (Dallas, Tex. : 1979)|January 19, 2005
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension studyHans Ibsen, Michael H Olsen, Kristian Wachtell, et al.Applied Optics|March 22, 2008
Mid-infrared w quantum-well lasers for noncryogenic continuous-wave operationC L Felix, W W Bewley, I Vurgaftman, et al.Pageof 126